Many previous studies have proved that immune checkpoint therapies (such as anti-PD-1/PD-L1 therapies) have extraordinary therapeutic effects in cancer patients and revolutionize the treatment standard for multiple cancers76. The gene discussed is CD274; the disease is cancer.